Pain and nausea after bariatric surgery with total intravenous anesthesia versus desflurane anesthesia: a double blind, randomized, controlled trial

被引:10
|
作者
Aftab, Hira [1 ,2 ,3 ]
Fagerland, Morten Wang [4 ]
Gondal, Ghous [1 ,2 ]
Ghanima, Waleed [3 ,5 ]
Olsen, Magnus Kringstad [5 ]
Nordby, Tom [1 ,2 ]
机构
[1] Ostfold Hosp Trust, Dept Morbid Obes & Bariatr Surg, Gralum, Norway
[2] Osybld Hosp Trust, Dept Gastrointestinal Surg, Gralum, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
[4] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Oslo, Norway
[5] Osyold Hosp Trust, Dept Res, Gralum, Norway
关键词
Gastric bypass; Gastric sleeve; Obesity; Volatile anesthesia; Peritoneal stretch; NRS; MORBIDLY OBESE-PATIENTS; MAINTENANCE; PROPOFOL; SEVOFLURANE; RECOVERY; LIVER; FAT;
D O I
10.1016/j.soard.2019.05.010
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: There is limited evidence-based knowledge regarding optimal anesthesia in obese patients. Objective: To evaluate optimal anesthetic approach for patients undergoing bariatric surgery by determining and comparing pen- and postoperative outcomes in patients receiving intravenous anesthesia with propofol versus desflurane anesthesia. Setting: Nonacademic primary referral center. Methods: Patients who underwent laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass between 2016 and 2017 were randomized into 1 of the following 2 types of anesthesia: intravenous anesthesia with propofol, or desflurane. Perioperative outcomes were registered by the operation staff. A form based on visual analog scale estimating the patient's intensity of pain and nausea was completed postoperatively at the postoperative unit, surgical ward, and 24 to 48 hours postsurgery. The primary outcome was postoperative nausea and vomiting or postoperative pain between treatment groups. The secondary outcome was to evaluate the "time of awakening," peritoneal stretch, and use of perioperative muscle relaxants. Results: One hundred eighty-three patients were randomized to receive intravenous anesthesia (n = 90) or desflurane anesthesia (n = 93). Mean time standard deviation of surgery for both procedures was 41 17 minutes, whereas mean time of awakening was 2 2 minutes for both the intravenous anesthesia and desflurane group. There was no significant difference in visual analog scale for pain or for nausea and vomiting postoperatively, nor in the number of patients receiving muscle relaxants for peritoneal stretch between the 2 groups. Conclusions: We found no significant differences between the 2 anesthetic regimens regarding postoperative nausea and pain, awakening time, peritoneal stretch, or the use of perioperative muscle relaxants. (C) 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1505 / 1512
页数:8
相关论文
共 50 条
  • [41] Impact of total intravenous anesthesia and total inhalation anesthesia as the anesthesia maintenance approaches on blood glucose level and postoperative complications in patients with type 2 diabetes mellitus: a double-blind, randomized controlled trial
    Xinghui Xiong
    Yong He
    Cheng Zhou
    Qin Zheng
    Chan Chen
    Peng Liang
    BMC Anesthesiology, 23
  • [42] Recovery characteristics of total intravenous anesthesia with propofol versus sevoflurane anesthesia: a prospective randomized clinical trial
    Kocaturk, Ozlem
    Keles, Sultan
    JOURNAL OF PAIN RESEARCH, 2018, 11 : 1289 - 1295
  • [43] Total Intravenous Anesthesia with Ketofol versus Combination of Ketofol and Lidocaine for Short-Term Anesthesia in Pediatric Patients; Double Blind, Randomized Clinical Trial of Effects on Recovery
    Biliskov, Ana Nevescanin
    Gulam, Danijela
    Zaja, Marija
    Pogorelic, Zenon
    CHILDREN-BASEL, 2022, 9 (02):
  • [44] The impact of inhalation versus total intravenous anesthesia on the immune status in patients undergoing breast cancer surgery: a double-blind randomized clinical trial (TeMP)
    Kadantseva, Kristina
    Subbotin, Valery
    Akchulpanov, Roman
    Berikashvili, Levan
    Yadgarov, Mikhail
    Zhukova, Lyudmila
    Kvetenadze, Guram
    Svitich, Oxana
    Kukina, Polina
    Kuznetsov, Ivan
    Shemetova, Mariya
    Smirnova, Anastasiya
    Polyakov, Petr
    Shebankov, Andrey
    Likhvantsev, Valery
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Opioid-free anesthesia in bariatric surgery: a prospective randomized controlled trial
    Christine Dagher
    Rhea Mattar
    Marie Aoun
    Joanna Tohme
    Nicole Naccache
    Hicham Jabbour
    European Journal of Medical Research, 30 (1)
  • [46] Effectiveness and safety of rocuronium or nitroglycerin plus ropivacaine on pain during intravenous regional anesthesia: A double-blind randomized controlled trial
    Alikhani, Shiva
    Modir, Hesameddin
    Moshiri, Esmail
    Kamali, Alireza
    Shahtaheri, Seyed Yosef
    JOURNAL OF ACUTE DISEASE, 2024, 13 (04) : 142 - 149
  • [47] Local anesthesia and pain perception during amniocentesis: a randomized double blind placebo-controlled trial
    Elimian, Andrew
    Goodman, Jean R.
    Knudtson, Eric
    Wagner, Andrew
    Wilson, Patrick
    Williams, Marvin
    PRENATAL DIAGNOSIS, 2013, 33 (12) : 1158 - 1161
  • [48] Effect of Volatile Anesthesia Versus Total Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial
    He, Lei -Lei
    Li, Xue-Fei
    Jiang, Jia-Li
    Yu, Hong
    Dai, Shun-Hui
    Jing, Wei-Wei
    Yu, Hai
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (10) : 3758 - 3765
  • [49] Intraoperative neurophysiological monitoring during spine surgery with total intravenous anesthesia or balanced anesthesia with 3 % desflurane
    Tod B. Sloan
    J. Richard Toleikis
    Sandra C. Toleikis
    Antoun Koht
    Journal of Clinical Monitoring and Computing, 2015, 29 : 77 - 85
  • [50] Inhalational Anesthesia is Noninferior to Total Intravenous Anesthesia in Terms of Surgical Field Visibility in Endoscopic Sinus Surgery: A Randomized, Double-Blind Study
    Li, He
    Du, Yingjie
    Yang, Wenjing
    Wang, Yue
    Su, Shaofei
    Zhao, Xiaoyan
    Wang, Guyan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 707 - 716